Patents by Inventor David L. Bremseth
David L. Bremseth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10646662Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: GrantFiled: August 21, 2017Date of Patent: May 12, 2020Assignee: Antares Pharma, Inc.Inventors: Peter L. Sadowski, Paul R. Lesch, David L. Bremseth
-
Publication number: 20190038483Abstract: An apparatus includes a support member having first and second ends. A door member is coupled to the support member and positioned on the first end. The door member is sized and shaped to fit over and removably couple to a top side of a vehicle door. A roof member is coupled to the support member and positioned on the second end. The roof member is sized and shaped to one of: fit over a vehicle roof rack, rest on a vehicle roof, and couple to a securing structure positioned on a vehicle roof.Type: ApplicationFiled: January 30, 2017Publication date: February 7, 2019Inventor: David L. Bremseth
-
Publication number: 20170340838Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: ApplicationFiled: August 21, 2017Publication date: November 30, 2017Applicant: Antares Pharma, Inc.Inventors: Peter L. Sadowski, Paul R. Lesch, David L. Bremseth
-
Patent number: 9737670Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: GrantFiled: April 5, 2016Date of Patent: August 22, 2017Assignee: ANTARES PHARMA, INC.Inventors: Peter L. Sadowski, Paul R. Lesch, David L. Bremseth
-
Publication number: 20160213859Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: ApplicationFiled: April 5, 2016Publication date: July 28, 2016Inventors: Peter L. Sadowski, Paul R. Lesch, David L. Bremseth
-
Patent number: 9333309Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: GrantFiled: June 22, 2014Date of Patent: May 10, 2016Assignee: Antares Pharma, Inc.Inventors: Peter L. Sadowski, Paul R. Lesch, Jr., David L. Bremseth
-
Publication number: 20140303558Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: ApplicationFiled: June 22, 2014Publication date: October 9, 2014Applicant: Antares Pharma, Inc.Inventors: Peter L. SADOWSKI, Paul R. LESCH, JR., David L. BREMSETH
-
Publication number: 20130231612Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: ApplicationFiled: April 5, 2013Publication date: September 5, 2013Applicant: Antares Pharma, Inc.Inventors: Peter L. SADOWSKI, Paul R. Lesch, JR., David L. Bremseth
-
Patent number: 8419686Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: GrantFiled: March 23, 2012Date of Patent: April 16, 2013Assignee: Antares Pharma, Inc.Inventors: Peter L. Sadowski, Paul R. Lesch, Jr., David L. Bremseth
-
Publication number: 20120179100Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: ApplicationFiled: March 23, 2012Publication date: July 12, 2012Applicant: ANTARES PHARMA, INC.Inventors: Peter L. Sadowski, Paul R. Lesch, JR., David L. Bremseth
-
Patent number: 8162886Abstract: An injection device that comprises a chamber configured for containing a substance to be injected and a needle operatively associated with the chamber and having a length sufficient to deliver the substance to an intradermal injection site. A collar surrounds the needle, defining a collar cavity. The collar also has a peripheral forward skin-contacting surface that surrounds and is radially spaced from the needle and injection site by an area that is sufficiently large to allow a patient's skin to move into the collar cavity to properly position the needle for intradermal delivery of the substance to the injection site to allow spread of the injected substance under the skin while inhibiting or preventing backpressure within the skin from forcing the substance out through the injection site.Type: GrantFiled: August 11, 2004Date of Patent: April 24, 2012Assignee: Antares Pharma, Inc.Inventors: Peter L. Sadowski, Paul R. Lesch, Jr., David L. Bremseth